NT-proBNP与院外心脏骤停昏迷幸存者的神经功能结局
这项回顾性多中心队列研究纳入2017年2月1日至2020年1月31日期间院外心脏骤停后入住ICU、且在自主循环恢复后24小时内测定NT-proBNP的昏迷患者301例,中位NT-proBNP为1108 pg/mL(IQR 163-3482)。多变量校正逻辑回归显示,NT-proBNP高于中位数与出院时不良神经功能结局(CPC 3-5分)风险升高相关(OR 2.50,95%CI 1.03-6.20;p=0.04),并与院内死亡风险升高相关(OR 2.30,95%CI 1.03-5.10;p=0.04)。按初始心律分层后,NT-proBNP升高仅在初始可电击心律患者中与不良神经功能结局(OR 7.80,95%CI 2.20-27.60;p=0.002)和死亡风险(OR 5.90,95%CI 1.60-22.20;p=0.009)相关,非可电击心律患者中无关联(交互作用p值分别为0.01和0.04)。
要点
- 院外心脏骤停后昏迷ICU患者中位NT-proBNP为1108 pg/mL(IQR 163-3482),高于中位数者出院不良神经功能结局风险升高(OR 2.50,95%CI 1.03-6.20)。
- NT-proBNP高于中位数与院内死亡风险升高独立相关(OR 2.30,95%CI 1.03-5.10)。
- 初始可电击心律患者中,NT-proBNP升高与不良神经功能结局强相关(OR 7.80,95%CI 2.20-27.60)及死亡风险升高(OR 5.90,95%CI 1.60-22.20)。
- 非可电击心律患者中NT-proBNP与结局无关联(交互作用p=0.01和0.04)。
- NT-proBNP测定时间为自主循环恢复后24小时内,临床解读需结合初始心律。
适用人群与场景
- 院外心脏骤停后入住ICU的昏迷患者,且在自主循环恢复后24小时内测定了NT-proBNP。
- 研究纳入时间为2017年2月1日至2020年1月31日。
诊断标准与关键阈值
- 不良神经功能结局定义为出院时脑功能分类(CPC)评分3-5分。
- NT-proBNP以中位数1108 pg/mL为界分为高于中位数与不高于中位数。
研究设计与关键结果
- 回顾性多中心队列研究,纳入301例院外心脏骤停后昏迷ICU患者,中位NT-proBNP 1108 pg/mL(IQR 163-3482)。
- 多变量校正逻辑回归:NT-proBNP高于中位数与不良神经功能结局风险升高相关(OR 2.50,95%CI 1.03-6.20;p=0.04),与院内死亡风险升高相关(OR 2.30,95%CI 1.03-5.10;p=0.04)。
- 按初始心律分层:可电击心律患者中NT-proBNP升高与不良神经功能结局相关(OR 7.80,95%CI 2.20-27.60;p=0.002),与死亡风险相关(OR 5.90,95%CI 1.60-22.20;p=0.009)。
- 非可电击心律患者中NT-proBNP与结局无关联(交互作用p=0.01和0.04)。
证据类型、等级与局限
- 证据类型:回顾性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在院外心脏骤停后昏迷ICU患者中,自主循环恢复后24小时内NT-proBNP高于中位数(1108 pg/mL)提示出院不良神经功能结局和院内死亡风险升高,尤其见于初始可电击心律患者。
- 非可电击心律患者中NT-proBNP与神经功能结局无关联,解读该标志物时需结合初始心律。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is an established biomarker associated with acute cardiovascular and cerebrovascular conditions, however its role in prognostication following OHCA is unclear and may be influenced by presenting rhythm. We sought to evaluate the association between NT-proBNP and neurologic outcomes in survivors of OHCA and to determine whether the association differed according to presenting rhythm.
METHODS: This retrospective multicenter cohort study included comatose patients admitted to the ICU after OHCA (2/1/2017 to 1/31/2020) with an NT-proBNP measured within 24 h of return of spontaneous circulation. The primary endpoint was poor neurologic outcome at hospital discharge defined as cerebral performance category (CPC) score 3-5.
RESULTS: The study included 301 patients with median NT-proBNP of 1108 pg/mL (IQR 163-3482). Multivariable adjusted logistic regression models revealed that NT-proBNP levels above the median were associated with increased risk of poor neurologic outcome (OR 2.50 [95 %CI 1.03-6.20]; p = 0.04) and increased risk of in-hospital mortality (2.30 [1.03-5.10]; p = 0.04). When stratified by presenting rhythm, elevated NT-proBNP was associated with an increased risk of poor neurologic outcome (7.80 [2.20-27.60]; p = 0.002) and increased risk of mortality (5.90 [1.60-22.20]; p = 0.009) among individuals with an initially shockable rhythm but no association among individuals with a non-shockable rhythm (p-interaction = 0.01 and 0.04 respectively).
CONCLUSION: NT-proBNP was independently associated with neurologic outcome and survival to hospital discharge in comatose survivors of OHCA admitted to the ICU. When stratified by presenting rhythm, NT-proBNP was only associated with outcomes among patients with a shockable rhythm.
参考来源
- Hamilton DE, Petek BJ, Mendez SR, et al. NT-proBNP and neurologic outcomes in comatose survivors of out-of-hospital cardiac arrest. Resuscitation. 2025. PMID: 40997993. doi:10.1016/j.resuscitation.2025.110844
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。